@FlorianIngelfi1@naturemethods@YosefLab@IdoAmitLab Congratulations Flo!! Very happy to see cytoVI out. I can highly recommend it, I‘ve been using it since the preprint came out and it totally revolutionized my HD flow workflow!
CytoVI is finally out in @naturemethods! We introduce our first deep generative model built for immunologists working with cytometry data to mitigate some of the most pressing limitations of the technology! Grateful for the fantastic collaboration with @YosefLab & @IdoAmitLab
I was such a blast to work on this project and I learned so much! Thank you to all the coauthors especially @ChiaraFalcomata and Bhavya Singh and Divya Chhamalwan!
(3/n)
A lot of cool tech went into this one, including Perturb-Map Multi-modal—a spatial CRISPR screen with dual Xenium-CyCIF readout, linking genetic perturbations directly to spatial immune phenotypes.
(2/n)
Pancreatic tumors are highly heterogeneous and immunosuppressive. But is immune resistance imposed across the whole tumor - or built locally by distinct cancer-cell states?
I’m incredibly excited to share our new paper, now out in @Nature! 🎉
https://t.co/jtEUKKFrBu
(1/7)
How do dendritic cells control tertiary lymphoid structures in cancer? Raphaël Mattiuz and @jboumelha just showed us how–just out in @ScienceMagazine. Happy I could contribute to this important piece. @MiriamMerad
https://t.co/aJulf4OS0E
Excited to share our new study @ScienceMagazine by the fantastic Raphael Mattiuz and @jboumelha@SinaiImmunol showing how DC build and sustain tertiary lymphoid structures in cancer. A major step toward enhancing anti-tumor immunity (1/2) https://t.co/H8awCDz0HM
hello world.
Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies.
Follow us for updates on systems immunology, machine learning & translational oncology.
fi
hello world.
Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies.
Follow us for updates on systems immunology, machine learning & translational oncology.
fi